The Aurora Funds

Metabolon develops metabolomics-based platforms and clinical diagnostic tests for early disease detection and precision medicine. It offers blood tests like QUANTOSE IR and QUANTOSE IGT, and Meta IMD for inherited metabolic disorders. The company serves various sectors including academia, biotech/pharmaceuticals, and precision medicine. It has strategic partnerships with major pharmaceutical companies and other industries.

Argos Therapeutics is a biotechnology company specializing in developing immunotherapy treatments for cancer and infectious diseases. It focuses on personalized immunotherapies using its proprietary Arcelis technology platform, with product candidates including rocapuldencel-T for metastatic renal cell carcinoma and AGS-004 for HIV.

Regado Biosciences is a biopharmaceutical company focused on the discovery and development of aptamer-based therapeutics, specifically targeting antidote-controlled treatments. Founded in 2001 and headquartered in Durham, North Carolina, the company is known for its innovative approach to antithrombotic therapies, including its lead product, REG1, which is designed for patients experiencing acute coronary syndrome undergoing coronary revascularization procedures. Regado's research emphasizes the development of therapeutic aptamers paired with active control agents, aiming to address both arterial and venous thrombosis effectively.

Argos Therapeutics is a biotechnology company specializing in developing immunotherapy treatments for cancer and infectious diseases. It focuses on personalized immunotherapies using its proprietary Arcelis technology platform, with product candidates including rocapuldencel-T for metastatic renal cell carcinoma and AGS-004 for HIV.

Metabolon develops metabolomics-based platforms and clinical diagnostic tests for early disease detection and precision medicine. It offers blood tests like QUANTOSE IR and QUANTOSE IGT, and Meta IMD for inherited metabolic disorders. The company serves various sectors including academia, biotech/pharmaceuticals, and precision medicine. It has strategic partnerships with major pharmaceutical companies and other industries.

Digitalsmiths is a technology company based in Durham, North Carolina, specializing in video indexing and digital content publishing. Founded in 2006, it provides video providers with the tools to access video archives and deliver personalized viewing experiences through precise and actionable video metadata. Its solutions are versatile, supporting various content formats and devices, which enhances user engagement and monetization opportunities across mobile, broadband, tablet, and television platforms. Digitalsmiths serves prominent clients in the entertainment industry, including major Hollywood studios, broadcasters, and publishers. The company's innovative algorithms facilitate effective video search and interpretation, allowing content owners and advertisers to maximize the value of their digital video assets.

Centice Corporation is a technology company based in Morrisville, North Carolina, specializing in drug detection and identification devices. Founded in 2003, Centice develops innovative solutions for identifying prescription drugs, illicit substances, and mixtures, including cannabinoids and bath salts. The company's flagship products include the PASS Rx system, which enhances the verification process for dispensed medications, and the PINPOINT Rx, a chemical verification product that captures the spectral signature of drugs for comparison against a known database. Centice's offerings support narcotics enforcement, diversion, interdiction, and counterfeiting efforts, and are distributed through a network of partners both in the United States and internationally. The company, originally known as Optopo, Inc., rebranded to Centice Corporation in February 2008.

Regado Biosciences is a biopharmaceutical company focused on the discovery and development of aptamer-based therapeutics, specifically targeting antidote-controlled treatments. Founded in 2001 and headquartered in Durham, North Carolina, the company is known for its innovative approach to antithrombotic therapies, including its lead product, REG1, which is designed for patients experiencing acute coronary syndrome undergoing coronary revascularization procedures. Regado's research emphasizes the development of therapeutic aptamers paired with active control agents, aiming to address both arterial and venous thrombosis effectively.

Metabolon develops metabolomics-based platforms and clinical diagnostic tests for early disease detection and precision medicine. It offers blood tests like QUANTOSE IR and QUANTOSE IGT, and Meta IMD for inherited metabolic disorders. The company serves various sectors including academia, biotech/pharmaceuticals, and precision medicine. It has strategic partnerships with major pharmaceutical companies and other industries.

Metabolon develops metabolomics-based platforms and clinical diagnostic tests for early disease detection and precision medicine. It offers blood tests like QUANTOSE IR and QUANTOSE IGT, and Meta IMD for inherited metabolic disorders. The company serves various sectors including academia, biotech/pharmaceuticals, and precision medicine. It has strategic partnerships with major pharmaceutical companies and other industries.

Digitalsmiths is a technology company based in Durham, North Carolina, specializing in video indexing and digital content publishing. Founded in 2006, it provides video providers with the tools to access video archives and deliver personalized viewing experiences through precise and actionable video metadata. Its solutions are versatile, supporting various content formats and devices, which enhances user engagement and monetization opportunities across mobile, broadband, tablet, and television platforms. Digitalsmiths serves prominent clients in the entertainment industry, including major Hollywood studios, broadcasters, and publishers. The company's innovative algorithms facilitate effective video search and interpretation, allowing content owners and advertisers to maximize the value of their digital video assets.

Centice Corporation is a technology company based in Morrisville, North Carolina, specializing in drug detection and identification devices. Founded in 2003, Centice develops innovative solutions for identifying prescription drugs, illicit substances, and mixtures, including cannabinoids and bath salts. The company's flagship products include the PASS Rx system, which enhances the verification process for dispensed medications, and the PINPOINT Rx, a chemical verification product that captures the spectral signature of drugs for comparison against a known database. Centice's offerings support narcotics enforcement, diversion, interdiction, and counterfeiting efforts, and are distributed through a network of partners both in the United States and internationally. The company, originally known as Optopo, Inc., rebranded to Centice Corporation in February 2008.

Digitalsmiths is a technology company based in Durham, North Carolina, specializing in video indexing and digital content publishing. Founded in 2006, it provides video providers with the tools to access video archives and deliver personalized viewing experiences through precise and actionable video metadata. Its solutions are versatile, supporting various content formats and devices, which enhances user engagement and monetization opportunities across mobile, broadband, tablet, and television platforms. Digitalsmiths serves prominent clients in the entertainment industry, including major Hollywood studios, broadcasters, and publishers. The company's innovative algorithms facilitate effective video search and interpretation, allowing content owners and advertisers to maximize the value of their digital video assets.

Regado Biosciences is a biopharmaceutical company focused on the discovery and development of aptamer-based therapeutics, specifically targeting antidote-controlled treatments. Founded in 2001 and headquartered in Durham, North Carolina, the company is known for its innovative approach to antithrombotic therapies, including its lead product, REG1, which is designed for patients experiencing acute coronary syndrome undergoing coronary revascularization procedures. Regado's research emphasizes the development of therapeutic aptamers paired with active control agents, aiming to address both arterial and venous thrombosis effectively.

Metabolon develops metabolomics-based platforms and clinical diagnostic tests for early disease detection and precision medicine. It offers blood tests like QUANTOSE IR and QUANTOSE IGT, and Meta IMD for inherited metabolic disorders. The company serves various sectors including academia, biotech/pharmaceuticals, and precision medicine. It has strategic partnerships with major pharmaceutical companies and other industries.

Metabolon develops metabolomics-based platforms and clinical diagnostic tests for early disease detection and precision medicine. It offers blood tests like QUANTOSE IR and QUANTOSE IGT, and Meta IMD for inherited metabolic disorders. The company serves various sectors including academia, biotech/pharmaceuticals, and precision medicine. It has strategic partnerships with major pharmaceutical companies and other industries.

Metabolon develops metabolomics-based platforms and clinical diagnostic tests for early disease detection and precision medicine. It offers blood tests like QUANTOSE IR and QUANTOSE IGT, and Meta IMD for inherited metabolic disorders. The company serves various sectors including academia, biotech/pharmaceuticals, and precision medicine. It has strategic partnerships with major pharmaceutical companies and other industries.

StemCo Biomedical, Inc. was founded in 1999 and is located in the Research Triangle Park area of NC. The Company is engaged in the development, manufacture and distribution of a series of medical products designed to improve therapeutic transplantation of adult hematopoetic stem and progenitor cells derived from bone marrow, peripheral blood or umbilical cord blood. Addressing a market of more than $1 billion annually, the Company will have a series of products on the market starting in 2002 that identify, sort and custom-engineer stem cell grafts based upon cellular expression of ALDH resulting in what may be better, more effective stem cell transplants in the future.

Regado Biosciences is a biopharmaceutical company focused on the discovery and development of aptamer-based therapeutics, specifically targeting antidote-controlled treatments. Founded in 2001 and headquartered in Durham, North Carolina, the company is known for its innovative approach to antithrombotic therapies, including its lead product, REG1, which is designed for patients experiencing acute coronary syndrome undergoing coronary revascularization procedures. Regado's research emphasizes the development of therapeutic aptamers paired with active control agents, aiming to address both arterial and venous thrombosis effectively.

Norak Biosciences, Inc., headquartered in Research Triangle Park, NC, is a private biotechnology company. Norak is utilizing its proprietary Transfluor technology to become a world leader in the discovery and development of drugs that regulate G protein-coupled receptors.

Regado Biosciences is a biopharmaceutical company focused on the discovery and development of aptamer-based therapeutics, specifically targeting antidote-controlled treatments. Founded in 2001 and headquartered in Durham, North Carolina, the company is known for its innovative approach to antithrombotic therapies, including its lead product, REG1, which is designed for patients experiencing acute coronary syndrome undergoing coronary revascularization procedures. Regado's research emphasizes the development of therapeutic aptamers paired with active control agents, aiming to address both arterial and venous thrombosis effectively.

StemCo Biomedical, Inc. was founded in 1999 and is located in the Research Triangle Park area of NC. The Company is engaged in the development, manufacture and distribution of a series of medical products designed to improve therapeutic transplantation of adult hematopoetic stem and progenitor cells derived from bone marrow, peripheral blood or umbilical cord blood. Addressing a market of more than $1 billion annually, the Company will have a series of products on the market starting in 2002 that identify, sort and custom-engineer stem cell grafts based upon cellular expression of ALDH resulting in what may be better, more effective stem cell transplants in the future.

Opsware, Inc. is a software company located in Sunnyvale, California, specializing in data center automation products aimed at enterprise customers, government agencies, and service providers across various industries. Originally founded as Loudcloud in 1999, the company transitioned to Opsware after divesting its managed services division in 2002. Opsware's offerings focus on server and network device provisioning, configuration, and management, leveraging automated server life-cycle management technology developed in-house. The company expanded its capabilities through strategic acquisitions, including Tangram Enterprise Solutions in 2003 for asset management, Rendition Networks in 2004 for network device configuration, CreekPath in 2006 for storage provisioning, and iConclude in 2007 for run-book automation. In July 2007, HP announced its intention to acquire Opsware for $1.6 billion, marking one of its largest acquisitions.

Accipiter offers online advertising solutions and services worldwide. It offers AdManager, an ad management solution that allows to increase targeting capabilities to speed ad delivery and to monitor and control inventory projections in real-time; Ad Trafficking, which provides AdManager hosted clients with outsourced and customized solution to administer the campaign management process; AdMarket, a real-time bid-for-placement technology enabling publishers to operate branded online advertising marketplaces and transact with advertisers who are requesting a pay-per-click pricing model; and Visitor Interest Behavioral Engine, a behavioral targeting solution that delivers promotions and content to interested prospects. Accipiter is based in Raleigh, North Carolina with an additional office in London, United Kingdom.

Accipiter offers online advertising solutions and services worldwide. It offers AdManager, an ad management solution that allows to increase targeting capabilities to speed ad delivery and to monitor and control inventory projections in real-time; Ad Trafficking, which provides AdManager hosted clients with outsourced and customized solution to administer the campaign management process; AdMarket, a real-time bid-for-placement technology enabling publishers to operate branded online advertising marketplaces and transact with advertisers who are requesting a pay-per-click pricing model; and Visitor Interest Behavioral Engine, a behavioral targeting solution that delivers promotions and content to interested prospects. Accipiter is based in Raleigh, North Carolina with an additional office in London, United Kingdom.